AUA2023 On Demand - AUA Annual Meeting

advertisement

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

  1. Home
  2. Attendee Info
  3. AUA2023 On Demand

AUA2023 On Demand

AUA2023 – Attendee Info

AUA2023 featured a wide range of content that is now available to be viewed on-demand thanks to educational grant support. Explore and view Instructional Courses, Live From AUA2023 Highlights and Satellite Symposia.

GU Cancers
Bladder Cancer
Prostate Cancer
Diversity, Equity and Inclusion
Overactive Bladder

GU Cancers

Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Genetics and Genomics of GU Malignancies—Applications into Your Clinical Practice

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Managing Toxicities of Checkpoint Inhibitors: A Urologist's Guide

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer

This activity is supported by educational grants from:
Astellas and Pfizer Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, Lilly, and Merck.

Claim CME

Beyond the Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Bladder Cancer

This activity is supported by educational grants from:
Bristol-Myers Squibb Company, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Merck.

Claim CME

Bladder Cancer

Upper Tract Urothelial Cancer Guidelines – An Interactive and Evidence-Based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video Presentation

Independent educational grant support provided by:
AstraZeneca, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Genetics and Genomics of GU Malignancies—Applications into Your Clinical Practice

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Managing Toxicities of Checkpoint Inhibitors: A Urologist's Guide

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Beyond the Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Bladder Cancer

This activity is supported by educational grants from:
Bristol-Myers Squibb Company, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Merck.

Claim CME

Prostate Cancer

How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

AUA Guidelines on Advanced Prostate Cancer

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Prostate Cancer Diagnosis: AUA Guidelines on use of PSA Biomarkers, MRI and Biopsy Techniques

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

The Changing Face of Advanced Prostate Cancer 2023

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Genetics and Genomics of GU Malignancies—Applications into Your Clinical Practice

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Managing Toxicities of Checkpoint Inhibitors: A Urologist's Guide

Independent educational grant support provided by:
Astellas, AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Pfizer, Inc.

Claim CME

Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer

This activity is supported by educational grants from:
Astellas and Pfizer Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, Lilly, and Merck.

Claim CME

The Role of PARP Inhibitors in Advanced Prostate Cancer

Independent educational grant support provided by:
Pfizer, Inc.

Claim CME

Diversity, Equity and Inclusion

Diversity Equity and Inclusion in Urology, What Do We Need to Know

Independent educational grant support provided by:
AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck & Co., Inc.

Claim CME

Advancing Gender Equity in Urology: Allyship for Men and Advocacy for Women

Independent educational grant support provided by:
AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck & Co., Inc.

Claim CME

What the General Urologist Should Know about Care of Transgender Patients

Independent educational grant support provided by:
AstraZeneca, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck & Co., Inc.

Claim CME

Overactive Bladder

Contemporary Pharmacotherapy for OAB 2023: Monotherapy and Combined Pharmacotherapy to Optimize Treatment

Independent educational grant support provided by:
Astellas, Urovant Sciences, Inc.

Claim CME

Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

Independent educational grant support provided by:
Astellas, Urovant Sciences, Inc.

Claim CME